CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 144 filers reported holding CASSAVA SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,343 | -30.9% | 11,499 | +1.9% | 0.00% | -100.0% |
| Q2 2023 | $276,806 | -5.5% | 11,289 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $293,034 | -18.3% | 12,149 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $358,881 | -46.0% | 12,149 | -23.5% | 0.00% | -50.0% |
| Q3 2022 | $664,000 | +48.5% | 15,879 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $447,000 | -17.2% | 15,879 | +9.1% | 0.00% | 0.0% |
| Q1 2022 | $540,000 | -15.1% | 14,549 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $636,000 | -33.0% | 14,549 | -4.8% | 0.00% | -50.0% |
| Q3 2021 | $949,000 | -24.2% | 15,279 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $1,252,000 | +120.0% | 14,659 | +15.9% | 0.00% | +100.0% |
| Q1 2021 | $569,000 | +532.2% | 12,650 | -3.8% | 0.00% | – |
| Q4 2020 | $90,000 | -40.4% | 13,150 | 0.0% | 0.00% | – |
| Q3 2020 | $151,000 | +268.3% | 13,150 | 0.0% | 0.00% | – |
| Q2 2020 | $41,000 | – | 13,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |